cagrilintide Snap-8 Semax CGL10 NP810 XA5 XA10 SK5 SK10 CAS868844-74-0
TDS 66 Inquiries
1415456-99-3
Pharmaceutical Grade
99%
shenzhen
sc
5 mg / 10 mg / 20 mg. 10 bottles per box
Yes
2027-04-13
tr
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Certificates-
TDS
Basic Info-
Product Name:
Cagrilintide
Other Name:Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide
CAS No.:1415456-99-3
Molecular Formula:C194H312N54O59S2
Molecular Weight:0
EC Number:206-141-6
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History66 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cagrilintide
20 MG Sep 30, 2026
United States
Cagrilintide
10 MG Sep 23, 2026
United States
cagrilintide
25 KG Sep 23, 2026
Germany
CAGRILINTIDE
50 MG Sep 21, 2026
United States
Cagrilintide
25 MG Aug 31, 2026
Australia
Cagrilintide
1 G Aug 25, 2026
Australia
Cagrilintide
20 MG Aug 17, 2026
United States
Retatrutid3
10 MT Aug 4, 2026
United States
Cagrlintide
1 MT Jul 31, 2026
United Kingdom
Cagrilintide
10 MG Jul 31, 2026
United States
Retatrutide
20 MT Jul 25, 2026
United Kingdom
cagrilintrude
20 MG Jul 21, 2026
United States
Cagrilintide
1 KG Jul 17, 2026
United States
Cagrilintide
10 MG Jul 13, 2026
Peru
Cagrilintide 20MG vial
10 PCS Jul 10, 2026
United States
Cagrilintide
30 MG May 26, 2026
France
Cagrilintide
10 MG May 22, 2026
New Zealand
Cagrilintide
10 MG May 19, 2026
United States
Cagrilintide
1 G May 18, 2026
United States
Cagrilintide
20 MG May 8, 2026 Post an enquiry for this product
More from this Seller
-
-
-
CBL60 cerebrolysin 60mg 5AD AOD KissPeptin-10 BPC 5mg + TB 5mg KS5 KS10 BB10 BB20 The best price
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
hyaluronic acid-5mg *1 vials Asetic Acid water 0.6% GT1500 RT60 SLU-PP-322 CS10 BPC10mg,TB10mg,GHK-CU50 RT50 KLOW80 AK100 VIP10 Sela
Pharmaceutical Grade / 99%
$1/G FOB
-
